Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations
- 1 February 1994
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 107 (2) , 554-561
- https://doi.org/10.1016/s0022-5223(12)70102-2
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Therapeutic Trial of Cerebral Vasospasm with the Serine Protease Inhibitor, FUT-175, Administered in the Acute Stage after Subarachnoid HemorrhageNeurosurgery, 1992
- Preventive Effect of Synthetic Serine Protease Inhibitor, FUT-175, on Cerebral Vasospasm in RabbitsNeurosurgery, 1992
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION IN PATIENTS WITH SEPTIC ENDOCARDITIS HAVING OPEN-HEART SURGERYThe Lancet, 1988
- Preoperative Aspirin Ingestion Increases Operative Blood Loss after Coronary Artery Bypass GraftingThe Annals of Thoracic Surgery, 1988
- Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary BypassThe Annals of Thoracic Surgery, 1987
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Clinical Application of Inhibitors of FibrinolysisDrugs, 1985
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Über die Inaktivierung des Kallikreins. (VI. Mitteilung über dieses Kreislaufhormon.)Hoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1930